Lipid Nanoparticles Delivery of CRISPR/Cas9 Targeting PCSK9 and ANGTPL3 as New Therapeutic Gene Editing Modalities for Potential Long-Lasting Treatment Of Dyslipidemia

Ramidha Syaharani

doi:https://doi.org/10.47119/IJRP100921120222750